314 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
BAX Baxter International Inc. $77.04 $41.16B N/A
Article Searches
QIAGEN (QGEN) Hurt by Low QuantiFERON-TB Sales & FX Headwind http://www.zacks.com/stock/news/527986/qiagen-qgen-hurt-by-low-quantiferon-tb-sales-fx-headwind?cid=CS-ZC-FT-analyst_blog|zer_report_update-527986 Sep 20, 2019 - Poor QuantiFERON-TB sales in Americas and an unfavourable currency translation affect QIAGEN's (QGEN) overall performance.
PRA Health Simplifies Treatment Decisions With Metys Launch http://www.zacks.com/stock/news/526206/pra-health-simplifies-treatment-decisions-with-metys-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526206 Sep 19, 2019 - PRA Health (PRAH) expects to enhance position and capabilities in the data and analytics field with the new tool, while simplifying treatment decisions.
Tandem Diabetes Posts Positive Data on t:slim X2 With Basal-IQ http://www.zacks.com/stock/news/526159/tandem-diabetes-posts-positive-data-on-tslim-x2-with-basal-iq?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526159 Sep 19, 2019 - Of late, Tandem Diabetes (TNDM) is investing in several developmental projects pertaining to the t:slim X2 insulin pump.
Here's Why You Should Retain Globus Medical (GMED) Stock Now http://www.zacks.com/stock/news/524674/heres-why-you-should-retain-globus-medical-gmed-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-524674 Sep 18, 2019 - Investor confidence continues to be high in Globus Medical (GMED), thanks to solid prospects.
Here's Why You Should Retain Pacific Biosciences For Now http://www.zacks.com/stock/news/524415/heres-why-you-should-retain-pacific-biosciences-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-524415 Sep 18, 2019 - Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, contraction in gross margin remains a woe.
Zimmer Biomet's New JuggerStitch to Grow Sports Medicine Line http://www.zacks.com/stock/news/524306/zimmer-biomets-new-juggerstitch-to-grow-sports-medicine-line?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-524306 Sep 18, 2019 - Zimmer Biomet's (ZBH) JuggerStitch claims to offer a less invasive, all-suture, knotless approach to meniscal repair procedures.
Abbott Receives European Nod for Pediatric Heart Devices http://www.zacks.com/stock/news/524246/abbott-receives-european-nod-for-pediatric-heart-devices?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-524246 Sep 18, 2019 - Abbott (ABT) aims to offer better treatment options for the most vulnerable patient population.
Intersect ENT Rides on Innovation Amid Pricing Concerns http://www.zacks.com/stock/news/522997/intersect-ent-rides-on-innovation-amid-pricing-concerns?cid=CS-ZC-FT-analyst_blog|zer_report_update-522997 Sep 17, 2019 - The SINUVA business line of Intersect ENT (XENT) makes a quick and remarkable progress with market access and field force balance.
HMS Holdings Acquires VitreosHealth, Boosts PHM Solution Set http://www.zacks.com/stock/news/522760/hms-holdings-acquires-vitreoshealth-boosts-phm-solution-set?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-522760 Sep 17, 2019 - HMS Holdings (HMSY) can leverage VitreosHealth's prescriptive health insights that will enhance its growing and lucrative PHM suite.
Here's Why You Should Retain OPKO Health (OPK) Stock For Now http://www.zacks.com/stock/news/522717/heres-why-you-should-retain-opko-health-opk-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-522717 Sep 17, 2019 - OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and solid R&D focus. However, operating losses remain a woe.

Pages: 123456...32

Page 1>